Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
doi: 10.3389/fimmu.2025.1690068 Received 21 August 2025 Accepted 03 October 2025 Published 16 October 2025 Volume 16 - 2025 Edited by Adil Rasheed, Augusta University, United States Reviewed by Zhi-Wei Wang, Wenzhou Medical University, China Yang Xiang, Peking Union Medical College Hospital (CAMS), China Updates Copyright 2025 Yang, Li, Shi, Zhong and Xiong
Behavioral paradigms such as Morris water maze and Y-maze offer quantifiable endpoints (Okada et al., 2021), that correlate with histopathological and molecular findings (Shokhirev and Johnson, 2022)
Environmental estrogen bisphenol A and autoimmunity
The treatments with Al + SeNP-MT 13 gained the biomass in root and shoot considerably over Al treatment
Aitken RJ, Bromfield EG, Gibb Z
For patients exploring weight management, GLP-1 peptide therapies (such as compounded semaglutide or tirzepatide from PlexusDx) have substantially more robust clinical evidence supporting appetite regulation and metabolic improvement
US$ 28.02
US$ 28.28
US$ 19.98
